<VariationArchive VariationID="370379" VariationName="NM_000478.6(ALPL):c.662dup (p.Gly222fs)" VariationType="Duplication" Accession="VCV000370379" Version="9" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-06-17" DateCreated="2017-01-09" MostRecentSubmission="2024-06-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="357062" VariationID="370379">
      <GeneList>
        <Gene Symbol="ALPL" FullName="alkaline phosphatase, biomineralization associated" GeneID="249" HGNC_ID="HGNC:438" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1p36.12</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="21508984" stop="21578410" display_start="21508984" display_stop="21578410" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="21835857" stop="21904904" display_start="21835857" display_stop="21904904" Strand="+" />
          </Location>
          <OMIM>171760</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000478.6(ALPL):c.662dup (p.Gly222fs)</Name>
      <CanonicalSPDI>NC_000001.11:21568111:GGGGGG:GGGGGGG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>1p36.12</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="21568111" stop="21568112" display_start="21568111" display_stop="21568112" variantLength="1" positionVCF="21568111" referenceAlleleVCF="T" alternateAlleleVCF="TG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="21894604" stop="21894605" display_start="21894604" display_stop="21894605" variantLength="1" positionVCF="21894604" referenceAlleleVCF="T" alternateAlleleVCF="TG" />
      </Location>
      <ProteinChange>G167fs</ProteinChange>
      <ProteinChange>G222fs</ProteinChange>
      <ProteinChange>G145fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.21894610dup" Assembly="GRCh37">
            <Expression>NC_000001.10:g.21894610dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.21568117dup" Assembly="GRCh38">
            <Expression>NC_000001.11:g.21568117dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008940.1" sequenceAccession="NG_008940" sequenceVersion="1" change="g.63753dup">
            <Expression>NG_008940.1:g.63753dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000478.6" sequenceAccession="NM_000478" sequenceVersion="6" change="c.662dup" MANESelect="true">
            <Expression>NM_000478.6:c.662dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000469.3" sequenceAccession="NP_000469" sequenceVersion="3" change="p.Gly222fs">
            <Expression>NP_000469.3:p.Gly222fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001127501.4" sequenceAccession="NM_001127501" sequenceVersion="4" change="c.497dup">
            <Expression>NM_001127501.4:c.497dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001120973.2" sequenceAccession="NP_001120973" sequenceVersion="2" change="p.Gly167fs">
            <Expression>NP_001120973.2:p.Gly167fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001177520.3" sequenceAccession="NM_001177520" sequenceVersion="3" change="c.431dup">
            <Expression>NM_001177520.3:c.431dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001170991.1" sequenceAccession="NP_001170991" sequenceVersion="1" change="p.Gly145fs">
            <Expression>NP_001170991.1:p.Gly145fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001369803.2" sequenceAccession="NM_001369803" sequenceVersion="2" change="c.662dup">
            <Expression>NM_001369803.2:c.662dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001356732.1" sequenceAccession="NP_001356732" sequenceVersion="1" change="p.Gly222fs">
            <Expression>NP_001356732.1:p.Gly222fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001369804.2" sequenceAccession="NM_001369804" sequenceVersion="2" change="c.662dup">
            <Expression>NM_001369804.2:c.662dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001356733.1" sequenceAccession="NP_001356733" sequenceVersion="1" change="p.Gly222fs">
            <Expression>NP_001356733.1:p.Gly222fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001369805.2" sequenceAccession="NM_001369805" sequenceVersion="2" change="c.662dup">
            <Expression>NM_001369805.2:c.662dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001356734.1" sequenceAccession="NP_001356734" sequenceVersion="1" change="p.Gly222fs">
            <Expression>NP_001356734.1:p.Gly222fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA16040717" DB="ClinGen" />
        <XRef Type="rs" ID="769948289" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000478.6(ALPL):c.662dup (p.Gly222fs) AND Infantile hypophosphatasia" Accession="RCV000412052" Version="2">
        <ClassifiedConditionList TraitSetID="3766">
          <ClassifiedCondition DB="MedGen" ID="C0268412">Infantile hypophosphatasia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2016-01-28" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000478.6(ALPL):c.662dup (p.Gly222fs) AND not provided" Accession="RCV001042114" Version="6">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-05-07" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000478.6(ALPL):c.662dup (p.Gly222fs) AND Adult hypophosphatasia" Accession="RCV004567875" Version="1">
        <ClassifiedConditionList TraitSetID="3768">
          <ClassifiedCondition DB="MedGen" ID="C0268413">Adult hypophosphatasia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-11-16" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-11-16" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2017-01-09" MostRecentSubmission="2024-06-17">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10679946</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18925618</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19500388</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">3174660</ID>
        </Citation>
        <DescriptionHistory Dated="2022-08-22">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2022-08-07">
          <Description>Pathogenic/Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2020-04-15">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="3768" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2275" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Adult hypophosphatasia</ElementValue>
                <XRef ID="Adult+hypophosphatasia/7639" DB="Genetic Alliance" />
                <XRef ID="MONDO:0007798" DB="MONDO" />
                <XRef ID="20756002" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Hypophosphatasia is characterized by defective mineralization of growing or remodeling bone, with or without root-intact tooth loss, in the presence of low activity of serum and bone alkaline phosphatase. Clinical features range from stillbirth without mineralized bone at the severe end to pathologic fractures of the lower extremities in later adulthood at the mild end. While the disease spectrum is a continuum, seven clinical forms of hypophosphatasia are usually recognized based on age at diagnosis and severity of features: Perinatal (severe): characterized by pulmonary insufficiency and hypercalcemia. Perinatal (benign): prenatal skeletal manifestations that slowly resolve into one of the milder forms. Infantile: onset between birth and age six months of clinical features of rickets without elevated serum alkaline phosphatase activity. Severe childhood (juvenile): variable presenting features progressing to rickets. Mild childhood: low bone mineral density for age, increased risk of fracture, and premature loss of primary teeth with intact roots. Adult: characterized by stress fractures and pseudofractures of the lower extremities in middle age, sometimes associated with early loss of adult dentition. Odontohypophosphatasia: characterized by premature exfoliation of primary teeth and/or severe dental caries without skeletal manifestations.</Attribute>
                <XRef ID="NBK1150" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301329</ID>
                <ID Source="BookShelf">NBK1150</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="pmc">3061990</ID>
              </Citation>
              <XRef ID="247676" DB="Orphanet" />
              <XRef ID="436" DB="Orphanet" />
              <XRef ID="C0268413" DB="MedGen" />
              <XRef Type="MIM" ID="146300" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3766" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2390" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Infantile hypophosphatasia</ElementValue>
                <XRef ID="Infantile+hypophosphatasia/8660" DB="Genetic Alliance" />
                <XRef ID="MONDO:0009427" DB="MONDO" />
                <XRef ID="55236002" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">HOPS</ElementValue>
                <XRef Type="MIM" ID="241500" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Hypophosphatasia is characterized by defective mineralization of growing or remodeling bone, with or without root-intact tooth loss, in the presence of low activity of serum and bone alkaline phosphatase. Clinical features range from stillbirth without mineralized bone at the severe end to pathologic fractures of the lower extremities in later adulthood at the mild end. While the disease spectrum is a continuum, seven clinical forms of hypophosphatasia are usually recognized based on age at diagnosis and severity of features: Perinatal (severe): characterized by pulmonary insufficiency and hypercalcemia. Perinatal (benign): prenatal skeletal manifestations that slowly resolve into one of the milder forms. Infantile: onset between birth and age six months of clinical features of rickets without elevated serum alkaline phosphatase activity. Severe childhood (juvenile): variable presenting features progressing to rickets. Mild childhood: low bone mineral density for age, increased risk of fracture, and premature loss of primary teeth with intact roots. Adult: characterized by stress fractures and pseudofractures of the lower extremities in middle age, sometimes associated with early loss of adult dentition. Odontohypophosphatasia: characterized by premature exfoliation of primary teeth and/or severe dental caries without skeletal manifestations.</Attribute>
                <XRef ID="NBK1150" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301329</ID>
                <ID Source="BookShelf">NBK1150</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="pmc">3061990</ID>
              </Citation>
              <XRef ID="247651" DB="Orphanet" />
              <XRef ID="436" DB="Orphanet" />
              <XRef ID="C0268412" DB="MedGen" />
              <XRef Type="MIM" ID="241500" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="949438" SubmissionDate="2016-11-23" DateLastUpdated="2022-12-24" DateCreated="2017-01-09">
        <ClinVarSubmissionID localKey="25299|OMIM:241500" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000485688" DateUpdated="2022-12-24" DateCreated="2017-01-09" Type="SCV" Version="2" SubmitterName="Counsyl" OrgID="320494" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-01-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">18925618</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Counsyl Autosomal and X-linked Recessive Disease Classification criteria (2015)</Attribute>
          <Citation Type="general">
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rb7nm21v/ar_xl2015criteria.pdf</URL>
            <CitationText>mdi-5618_320494_Counsyl Autosomal and X-linked Recessive Disease Classification criteria (2015).pdf</CitationText>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ALPL" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000478.4:c.662dupG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="241500" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>Counsyl2016</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2371015" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="4813911|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001205778" DateUpdated="2024-02-14" DateCreated="2020-04-15" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-05-07">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">3174660</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10679946</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19500388</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18925618</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in ALPL are known to be pathogenic (PMID: 3174660, 10679946, 19500388). This variant has been observed in a fetus with clinical features of hypophosphatasia (PMID: 18925618). This variant is also known as 662insG in the literature. ClinVar contains an entry for this variant (Variation ID: 370379). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Gly222Trpfs*10) in the ALPL gene. It is expected to result in an absent or disrupted protein product.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ALPL" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.10:g.21894604_21894605insG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9811157" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-17" DateCreated="2024-06-17">
        <ClinVarSubmissionID localKey="NM_000478.6:c.662dup|OMIM:146300" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV005053348" DateUpdated="2024-06-17" DateCreated="2024-06-17" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-16">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000478.6:c.662dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="146300" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GA_HC_20231102_20240331</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="949438" TraitType="Disease" MappingType="XRef" MappingValue="241500" MappingRef="OMIM">
        <MedGen CUI="C0268412" Name="Infantile hypophosphatasia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9811157" TraitType="Disease" MappingType="XRef" MappingValue="146300" MappingRef="OMIM">
        <MedGen CUI="C0268413" Name="Adult hypophosphatasia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2371015" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

